Lipella Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LIPO and buy or sell other stocks, ETFs, and their options commission-free!About LIPO
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent.
CEOJonathan Kaufman
CEOJonathan Kaufman
Employees7
Employees7
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2005
Founded2005
Employees7
Employees7
LIPO Key Statistics
Market cap10.54M
Market cap10.54M
Price-Earnings ratio-3.97
Price-Earnings ratio-3.97
Dividend yield—
Dividend yield—
Average volume434.56K
Average volume434.56K
High today—
High today—
Low today—
Low today—
Open price$1.75
Open price$1.75
Volume0.00
Volume0.00
52 Week high$1.50
52 Week high$1.50
52 Week low$0.2804
52 Week low$0.2804
People also own
Based on the portfolios of people who own LIPO. This list is generated using Robinhood data, and it’s not a recommendation.